Cleared Traditional

K893499 - CMS FAST CUT, CMS DIAMOND AND CMS WIRE PASS (FDA 510(k) Clearance)

Class I Ear, Nose, Throat device.

K893499 · Cmsi · Ear, Nose, Throat device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1989
Decision
196d
Days
Class 1
Risk

K893499 is an FDA 510(k) clearance for the CMS FAST CUT, CMS DIAMOND AND CMS WIRE PASS. Classified as Bur, Ear, Nose And Throat (product code EQJ), Class I - General Controls.

Submitted by Cmsi (South Bend, US). The FDA issued a Cleared decision on November 16, 1989 after a review of 196 days - an extended review cycle.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.4140 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.

View all Cmsi devices

Submission Details

510(k) Number K893499 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 1989
Decision Date November 16, 1989
Days to Decision 196 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
107d slower than avg
Panel avg: 89d · This submission: 196d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code EQJ Bur, Ear, Nose And Throat
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 874.4140
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.